Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Pluristem’s PLX Cells Show Efficacy in Treating Lung Disease  

 

 

Pluristem’s PLX Cells Show Efficacy in Treating Lung Disease 

July 31, 2012 - (Pluristem) - "Pluristem Therapeutics, Inc, a leading developer of placenta-based cell therapies, today announced the results of new preclinical tests that show its PLacental eXpanded (PLX) cells may be effective in reducing pulmonary fibrosis and improving lung function in a group of diseases collectively called interstitial lung disease (ILD). ILD includes the pulmonary insults occurring in the lung following its exposure to drugs, radiation or toxic chemicals and the pulmonary complications of systemic autoimmune diseases."  Read Full Article

 

Posted on 13-Aug-12 by Toto, Brent
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: